CDKN2A and melanoma: For future studies, it will therefore be interesting to further unravel the exact regulatory mechanisms of MYSM1 induction during melanocyte transformation to melanoma and melanoma metastases as well as to further investigate the interplay with factors commonly altered in melanoma such as BRAF, N-RAS, PTEN, CDKN2A, p53, and others.